Gavekal Capital buys $8,897,659 stake in Stryker Corporation (SYK)

Stryker Corporation (SYK) : Gavekal Capital scooped up 12,347 additional shares in Stryker Corporation during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Oct 17, 2016. The investment management firm now holds a total of 78,290 shares of Stryker Corporation which is valued at $8,897,659.Stryker Corporation makes up approximately 3.04% of Gavekal Capital’s portfolio.

Other Hedge Funds, Including , Chesley Taft Associates reduced its stake in SYK by selling 1,414 shares or 1.25% in the most recent quarter. The Hedge Fund company now holds 112,103 shares of SYK which is valued at $12,740,506. Stryker Corporation makes up approx 1.31% of Chesley Taft Associates’s portfolio.First Financial Bank N.a. – Trust Division reduced its stake in SYK by selling 530 shares or 1.26% in the most recent quarter. The Hedge Fund company now holds 41,374 shares of SYK which is valued at $4,875,926. Stryker Corporation makes up approx 0.90% of First Financial Bank N.a. – Trust Division’s portfolio.Centre Asset Management reduced its stake in SYK by selling 9,110 shares or 7.6% in the most recent quarter. The Hedge Fund company now holds 110,750 shares of SYK which is valued at $13,051,888. Stryker Corporation makes up approx 2.38% of Centre Asset Management’s portfolio. Hefty Wealth Partners added SYK to its portfolio by purchasing 1,658 company shares during the most recent quarter which is valued at $193,422. Stryker Corporation makes up approx 0.15% of Hefty Wealth Partners’s portfolio.

Stryker Corporation opened for trading at $116.18 and hit $116.18 on the upside on Friday, eventually ending the session at $113.65, with a gain of 0.06% or 0.07 points. The heightened volatility saw the trading volume jump to 12,53,605 shares. Company has a market cap of $42,539 M.

On the company’s financial health, Stryker Corporation reported $1.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Apr 20, 2016. Analyst had a consensus of $1.20. The company had revenue of $2495.00 million for the quarter, compared to analysts expectations of $2471.86 million. The company’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.11 EPS.

Many Wall Street Analysts have commented on Stryker Corporation. Stryker Corporation was Initiated by SunTrust to “Buy” on Oct 14, 2016.

Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Stryker Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Stryker Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.